Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for Paroxysmal Atrial Fibrillation
NCT05292209Phase 2Recruiting
- Sponsor
- University of Utah
- Start
- Jun 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riluzole in Atrial fibrillation (AFib), sponsored by University of Utah. Started Jun 2022; status: recruiting.
02
Drugs
riluzole
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05292209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05292209.